Literature DB >> 16175755

Psychosocial functioning and quality of life in body dysmorphic disorder.

Katharine A Phillips1, William Menard, Christina Fay, Maria E Pagano.   

Abstract

Psychosocial functioning and quality of life in body dysmorphic disorder (BDD) have received only limited investigation. We examined these domains in 176 subjects with current Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV), BDD using reliable measures, several of which have not been used previously in BDD studies. Scores were compared to published norms. On the Medical Outcomes Study 36-Item Short-Form Health Survey, mental health-related quality of life scores for BDD subjects were approximately 1.8 SD units poorer than US population norms and 0.4 SD units poorer than norms for depression. On the Quality of Life Enjoyment and Satisfaction Questionnaire Short Form, BDD subjects had a mean converted score of 49.9% +/- 16.4%, which was 2.1 SD units poorer than the normative community sample score of 78.1% +/- 13.7%. On the Social Adjustment Scale-Self-Report, BDD subjects had a mean Overall Adjustment total score of 2.37 +/- 0.52, which was 2.4 SD units poorer than the published norm of 1.59 +/- 0.33. Scores on the Range of Impaired Functioning Tool reflected functional impairment in all domains. More severe BDD symptoms were significantly associated with poorer functioning and quality of life on all measures. On all but one measure, functioning and quality of life for subjects who were not currently receiving mental health treatment did not significantly differ from those who were receiving treatment. These findings indicate that individuals with BDD, regardless of treatment status, have markedly poor functioning and quality of life. In addition, they suggest that treatment should aim at improving functioning and quality of life in addition to relieving symptoms.

Entities:  

Mesh:

Year:  2005        PMID: 16175755      PMCID: PMC1351256          DOI: 10.1016/j.comppsych.2004.10.004

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  30 in total

1.  Pharmacologic treatment of body dysmorphic disorder: review of the evidence and a recommended treatment approach.

Authors:  Katharine A Phillips
Journal:  CNS Spectr       Date:  2002-06       Impact factor: 3.790

2.  Perceived stress in body dysmorphic disorder.

Authors:  L M DeMarco; L C Li; K A Phillips; S L McElroy
Journal:  J Nerv Ment Dis       Date:  1998-11       Impact factor: 2.254

3.  Quality-of-life impairment in depressive and anxiety disorders.

Authors:  Mark Hyman Rapaport; Cathryn Clary; Rana Fayyad; Jean Endicott
Journal:  Am J Psychiatry       Date:  2005-06       Impact factor: 18.112

4.  A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder.

Authors:  Katharine A Phillips; Ralph S Albertini; Steven A Rasmussen
Journal:  Arch Gen Psychiatry       Date:  2002-04

5.  Posttraumatic stress disorder and quality of life: results across 64 weeks of sertraline treatment.

Authors:  Mark H Rapaport; Jean Endicott; Cathryn M Clary
Journal:  J Clin Psychiatry       Date:  2002-01       Impact factor: 4.384

6.  Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure.

Authors:  J Endicott; J Nee; W Harrison; R Blumenthal
Journal:  Psychopharmacol Bull       Date:  1993

7.  Prospective study of fluoxetine treatment and suicidal behavior in affectively ill subjects.

Authors:  A C Leon; M B Keller; M G Warshaw; T I Mueller; D A Solomon; W Coryell; J Endicott
Journal:  Am J Psychiatry       Date:  1999-02       Impact factor: 18.112

Review 8.  Body dysmorphic disorder.

Authors:  J A Cotterill
Journal:  Dermatol Clin       Date:  1996-07       Impact factor: 3.478

9.  Change in psychosocial functioning and quality of life of patients with body dysmorphic disorder treated with fluoxetine: a placebo-controlled study.

Authors:  Katharine A Phillips; Steven A Rasmussen
Journal:  Psychosomatics       Date:  2004 Sep-Oct       Impact factor: 2.386

10.  The relationship between fluoxetine use and suicidal behavior in 654 subjects with anxiety disorders.

Authors:  M G Warshaw; M B Keller
Journal:  J Clin Psychiatry       Date:  1996-04       Impact factor: 4.384

View more
  36 in total

Review 1.  Body dysmorphic disorder: some key issues for DSM-V.

Authors:  Katharine A Phillips; Sabine Wilhelm; Lorrin M Koran; Elizabeth R Didie; Brian A Fallon; Jamie Feusner; Dan J Stein
Journal:  Depress Anxiety       Date:  2010-06       Impact factor: 6.505

2.  A retrospective follow-up study of body dysmorphic disorder.

Authors:  Katharine A Phillips; Jon E Grant; Jason M Siniscalchi; Robert Stout; Lawrence H Price
Journal:  Compr Psychiatry       Date:  2005 Sep-Oct       Impact factor: 3.735

3.  Social functioning in body dysmorphic disorder: assessment considerations.

Authors:  Elizabeth R Didie; Christina Tortolani; Mary Walters; William Menard; Christina Fay; Katharine A Phillips
Journal:  Psychiatr Q       Date:  2006

4.  Childhood abuse and neglect in body dysmorphic disorder.

Authors:  Elizabeth R Didie; Christina C Tortolani; Courtney G Pope; William Menard; Christina Fay; Katharine A Phillips
Journal:  Child Abuse Negl       Date:  2006-09-26

5.  Cued panic attacks in body dysmorphic disorder.

Authors:  Katharine A Phillips; William Menard; Andri S Bjornsson
Journal:  J Psychiatr Pract       Date:  2013-05       Impact factor: 1.325

6.  Personal and appearance-based rejection sensitivity in body dysmorphic disorder.

Authors:  Megan M Kelly; Elizabeth R Didie; Katharine A Phillips
Journal:  Body Image       Date:  2014-04-13

Review 7.  Cognitive-behavioral therapy for youth with body dysmorphic disorder: current status and future directions.

Authors:  Katharine A Phillips; Jamison Rogers
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2011-04

8.  The phenomenology of self-reported body dysmorphic disorder by proxy.

Authors:  Jennifer L Greenberg; Martha Falkenstein; Lillian Reuman; Jeanne Fama; Luana Marques; Sabine Wilhelm
Journal:  Body Image       Date:  2013-02-04

9.  Prevalence and clinical characteristics of body dysmorphic disorder in an adult inpatient setting.

Authors:  Michelle Conroy; William Menard; Kathryn Fleming-Ives; Poonam Modha; Hilary Cerullo; Katharine A Phillips
Journal:  Gen Hosp Psychiatry       Date:  2008 Jan-Feb       Impact factor: 3.238

10.  Body dysmorphic disorder: treating an underrecognized disorder.

Authors:  Katharine A Phillips; Elizabeth R Didie; Jamie Feusner; Sabine Wilhelm
Journal:  Am J Psychiatry       Date:  2008-09       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.